BRIANNA COOK: Open Payments
NPI 1396588943 · SHELBY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,395 in 74 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $535 · 2025 $1,395
Food & beverage: $1,395
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 13 | $333 |
| Calliditas Therapeutics US Inc. | 10 | $264 |
| AstraZeneca Pharmaceuticals LP | 12 | $237 |
| Otsuka America Pharmaceutical, Inc. | 20 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $103 |
| AKEBIA THERAPEUTICS INC | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| Lilly USA, LLC | 2 | $34 |
| Ardelyx, Inc. | 1 | $28 |
| Vifor Pharma, Inc. | 1 | $28 |
Products named: TARPEYO, FARXIGA, JYNARQUE, Kerendia, Vafseo, JARDIANCE, Fabhalta, IBSRELA.
Industry payments across NC — which companies pay providers there.
